Cytomegalovirus Colitis in a Patient with Severe Treatment Refractory Ulcerative Colitis

CONCLUSIONS: Despite our patient having multiple risk factors for developing CMV colitis, upadacitinib may have played a role when considering its known impact on the herpes family of viruses. CMV colitis should be evaluated for in any patient who presents with worsening symptoms without evidence of other infection or response to increase in therapy.PMID:38444641 | PMC:PMC10914341 | DOI:10.1093/crocol/otae014

Source: Herpes - March 6, 2024 Category: Infectious Diseases Authors: Michelle M Bao Juliana M Kennedy Michael T Dolinger David Dunkin Joanne Lai Marla C Dubinsky Source Type: research